메뉴 건너뛰기




Volumn 6, Issue 2, 2002, Pages 142-160

Philadelphia chromosome-positive acute lymphoblastic leukemia - Current concepts and future perspectives

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BCR ABL PROTEIN P90; GENE PRODUCT; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

EID: 0036341359     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-0734.2002.00066.x     Document Type: Review
Times cited : (46)

References (90)
  • 1
    • 0028762431 scopus 로고
    • Mechanisms of disease - The molecular basis of leukemia
    • (1994) N Engl J Med , vol.330 , pp. 328-336
    • Cline, M.J.1
  • 3
    • 0015694748 scopus 로고
    • A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
    • (1970) Nature , vol.243 , pp. 290-293
    • Rowley, J.D.1
  • 5
    • 0028238230 scopus 로고
    • Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients
    • (1994) Am J Med , vol.97 , pp. 60-65
    • Preti, H.A.1    O'Brien, S.2    Giralt, S.3
  • 13
    • 0033754724 scopus 로고    scopus 로고
    • Novel BCR-ABL transcript containing and intronic sequence insert in a patient with Philadelphia-positive acute lymphoblastic leukaemia
    • (2000) Br J Haematol , vol.110 , pp. 867-870
    • Hirota, M.1    Hidaka, E.2    Ueno, I.3
  • 16
    • 0029895899 scopus 로고    scopus 로고
    • p190 bcr-abl mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias
    • (1996) Blood , vol.87 , pp. 5213-5217
    • Van Rhee, F.1    Hochhaus, A.2    Lin, F.3
  • 18
  • 19
    • 0027499430 scopus 로고
    • Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: A review
    • (1993) Leukemia , vol.7 , pp. 147-151
    • Secker-Walker, L.M.1    Craig, J.M.2
  • 20
    • 0029892567 scopus 로고    scopus 로고
    • Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: Chronic myelogenous leukemia presenting in lymphoid blast phase vs Ph+ acute lymphoblastic leukemia
    • (1996) Leukemia , vol.10 , pp. 795-802
    • Anastasi, J.1    Feng, J.2    Dickstein, J.I.3
  • 23
    • 0034090054 scopus 로고    scopus 로고
    • The existence of lymphoid lineage restricted Philadelphia chromosome positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    • (2000) Leukemia , vol.14 , pp. 1122-1126
    • Pajor, L.1    Vass, J.A.2    Kereskai, L.3
  • 27
    • 0032529306 scopus 로고    scopus 로고
    • The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: An in vivo model of chronic myelogenous leukemia biology
    • (1998) Blood , vol.92 , pp. 1390-1396
    • Dazzi, F.1    Capelli, D.2    Hasserjian, R.3
  • 31
    • 0032520986 scopus 로고    scopus 로고
    • Development of acute lymphoblastic leukemia and myelogproliferative disorder in transgenic mice expressing p210 bcr/abl: A novel transgenic model for human Ph1-positive leukemias
    • (1998) Blood , vol.91 , pp. 2067-2075
    • Honda, H.1    Oda, H.2    Suzuki, T.3
  • 32
    • 0026576755 scopus 로고
    • Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
    • (1992) Mol Cell Biol , vol.12 , pp. 1755-1763
    • Elefanty, A.G.1    Cory, S.2
  • 39
    • 0029098199 scopus 로고
    • Hypermetaphase fluorescence in situ hybridization for quantitative monitoring Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment
    • (1995) Blood , vol.86 , pp. 2343-2349
    • Seong, D.1    Kantarjian, H.M.2    Ro, J.Y.3
  • 40
    • 0032079490 scopus 로고    scopus 로고
    • Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia
    • (1998) Blood , vol.91 , pp. 3357-3365
    • Dewald, G.W.1    Wyatt, W.A.2    Juneau, A.L.3
  • 45
    • 0028938844 scopus 로고
    • A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811
    • (1995) Blood , vol.85 , pp. 2025-2037
    • Larson, R.A.1    Dodge, R.K.2    Burns, C.P.3
  • 46
    • 0029867127 scopus 로고    scopus 로고
    • Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogénétique Hématologique
    • (1996) Blood , vol.87 , pp. 3135-3142
  • 50
    • 0033153105 scopus 로고    scopus 로고
    • Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B Experience
    • (1999) Blood , vol.93 , pp. 3983-3993
    • Wetzler, M.1    Dodge, R.K.2    Mrózek, K.3
  • 54
    • 0035203227 scopus 로고    scopus 로고
    • Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: A single institution experience of 378 consecutive patients over a 21-year period
    • (2001) Leukemia , vol.15 , pp. 1811-1822
    • Thomas, X.1    Danaïla, C.2    Le, Q.-H.3
  • 55
    • 0036464686 scopus 로고    scopus 로고
    • Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 randomized study
    • (2002) Blood , vol.99 , pp. 863-871
    • Annino, L.1    Vegna, M.L.2    Camera, A.3
  • 56
    • 0025091057 scopus 로고
    • Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study
    • (1990) Blood , vol.76 , pp. 489-494
    • Crist, W.1    Carroll, A.2    Shuster, J.3
  • 57
    • 8944251627 scopus 로고    scopus 로고
    • Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92
    • (1996) Leukemia , vol.10 , pp. 957-963
    • Schlieben, S.1    Borkhardt, A.2    Reinisch, I.3
  • 58
    • 0030870639 scopus 로고    scopus 로고
    • Philadelphia chromosome-positive acute lymphoblastic leukemia in children: Durable responses to chemotherapy associated with low initial white blood cell counts
    • (1997) Leukemia , vol.11 , pp. 1493-1496
    • Ribeiro, R.C.1    Broniscer, A.2    Rivera, G.K.3
  • 59
    • 0032532289 scopus 로고    scopus 로고
    • +) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome
    • (1998) Blood , vol.92 , pp. 2730-2741
    • Schrappe, M.1    Aricó, M.2    Harbott, J.3
  • 62
    • 0034210549 scopus 로고    scopus 로고
    • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90
    • (2000) Blood , vol.95 , pp. 3310-3322
    • Schrappe, M.1    Reiter, A.2    Ludwig, W.-D.3
  • 63
    • 0035021732 scopus 로고    scopus 로고
    • Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol
    • (2001) Br J Haematol , vol.113 , pp. 103-114
    • Hann, I.1    Vora, A.2    Harrison, G.3
  • 64
    • 0031002040 scopus 로고    scopus 로고
    • Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after bone marrow transplantation
    • (1997) Blood , vol.89 , pp. 2602-2609
    • Radich, J.1    Gehly, G.2    Lee, A.3
  • 65
    • 0009996654 scopus 로고    scopus 로고
    • Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Results from the International ALL Trial (MRC UKALLXII/ECOG E2993)
    • (2001) Blood , vol.98
    • Goldstone, A.H.1    Prentice, H.G.2    Durrant, J.3
  • 68
    • 0030749222 scopus 로고    scopus 로고
    • Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
    • (1997) Blood , vol.90 , pp. 1410-1414
    • Sierra, J.1    Radich, J.2    Hansen, J.A.3
  • 72
    • 0032756124 scopus 로고    scopus 로고
    • Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
    • (1999) Leukemia , vol.13 , pp. 2053-2058
    • Snyder, D.S.1    Nademanee, A.P.2    O'Donnell, M.R.3
  • 73
    • 0035869381 scopus 로고    scopus 로고
    • Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: Strong graft-versus-leukemia effect and risk factors determining outcome
    • (2001) Blood , vol.97 , pp. 1572-1577
    • Cornelissen, J.J.1    Carston, M.2    Kollman, C.3
  • 74
    • 0034307685 scopus 로고    scopus 로고
    • Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: Results from Medical Research Council UKALL X and XI
    • (2000) Blood , vol.96 , pp. 2412-2418
    • Wheeler, K.A.1    Richards, S.M.2    Bailey, C.C.3
  • 77
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the BCR-ABL tyrosine kinas in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
    • (2001) N Engl J Med , vol.344 , pp. 1038-1042
    • Druker, B.J.1    Sawyers, C.L.2    Kantarjian, H.3
  • 79
    • 16944365948 scopus 로고    scopus 로고
    • Good correlation between RT-PCR analysis and relpase in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)
    • (1997) Leukemia , vol.11 , pp. 294-298
    • Preudhomme, C.1    Henic, N.2    Cazin, B.3
  • 80
    • 0032865769 scopus 로고    scopus 로고
    • Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymhoblastic leukaemia using quantitative competitive polymerase chain reaction
    • (1999) Br J Haematol , vol.106 , pp. 634-643
    • Mitterbauer, G.1    Nemeth, P.2    Wacha, S.3
  • 81
    • 0000165420 scopus 로고    scopus 로고
    • Prognostic relevance of minimal residual disease (MRD) analysis in BCR-ABL positive acute lymphoblastic leukemia (ALL) patients during Gleevec (STI571) therapy
    • (2001) Blood , vol.98
    • Scheuring, U.J.1    Pfeifer, H.2    Brueck, P.3
  • 85
    • 79960971702 scopus 로고    scopus 로고
    • Transduction of dendritic cells with the p190 Bcr-Abl oncogene elicits autologous T cell proliferation
    • (2001) Blood , vol.98
    • Gruber, T.A.1    Kohn, D.B.2
  • 86
    • 0033826799 scopus 로고    scopus 로고
    • Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
    • (2000) Nat Med , vol.6 , pp. 1018-1023
    • Molldrem, J.1    Lee, P.P.2    Wang, C.3
  • 89
    • 0003285566 scopus 로고    scopus 로고
    • Combination of Hyper-CVAD with Imatinib Mesylate (STI571) for Philadelphia (Ph)-positive adult acute lymphoblastic leukemia (ALL) or chronic myelogenous leukemia in lymphoid blast phase (CML-LBP)
    • (2001) Blood , vol.98
    • Thomas, D.A.1    Cortes, J.2    Giles, F.J.3
  • 90
    • 0000780801 scopus 로고    scopus 로고
    • Activity of the ABL-tyrosine kinase inhibitor Glivec (STI571) in Philadelphia chromosome positive acute lymphoblastic leukemia (PH+ALL) relapsing after allogeneic stem cell transplantation (allo-SCT)
    • (2001) Blood , vol.98
    • Ottmann, O.G.1    Wassmann, B.2    Pfeifer, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.